Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review.

Sheth, Hardik; Limaye, Sewanti; Kumar, Prashant; Shreenivas, Aditya

Sheth, Hardik; Limaye, Sewanti; Kumar, Prashant; Shreenivas, Aditya.

Afiliación

Sheth H; Department of General Medicine, D Y Patil University School of Medicine, Mumbai, Maharashtra, India.
Limaye S; Department of Medical Oncology, Sir HN Reliance Foundation Hospital and Research Center, Mumbai, Maharashtra, India.
Kumar P; Karkinos Healthcare Pvt Ltd, Mumbai, Maharashtra, India.
Shreenivas A; Department of Medical Oncology, Cancer Center Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, USA. ashreenivas@mcw.edu.

J Cancer Res Clin Oncol ; 149(8): 4915-4923, 2023 Jul.

Article en En | MEDLINE | ID: mdl-36307559

Asunto(s)

Adenocarcinoma; Neoplasias de la Vesícula Biliar; Humanos; Masculino; Anciano; Neoplasias de la Vesícula Biliar/tratamiento farmacológico; Neoplasias de la Vesícula Biliar/genética; Mutación

Palabras clave

Futibatinib; Gallbladder cancer; Pathway resistance; Pemigatinib; Sequential anti-FGFR therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias de la Vesícula Biliar Límite: Aged / Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google